Alcon bought Aerie Pharmaceuticals Aerie Pharmaceuticals from 11/22/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Alcon completed its acquisition of Aerie Pharmaceuticals for $770 million, or 15.25 per share.

Aerie Pharmaceuticals

Review

Source:

{source} pictogram

investor.alcon.com

Vladimir Petenev

News editor

Write your comment first

News feed

Yandex to issue 15.61 million shares for incentive program

8/8/24 YDEX

Board of Directors of Yandex recommended that dividends

8/8/24 YDEX

MD Medical opened a medical center in Anapa

8/8/24 MDMG

Rusagro began preparing for forced redomiciliation

8/8/24 AGRO

Rostelecom reorganized IT assets

8/8/24 RTKM

Fix Price in July opened its first store in the UAE

8/8/24 FIXP

Magnit closed a deal to buy 33% of Samberi

8/8/24 MGNT

Fix Price has reported for 6 months of 2024

8/8/24 FIXP

Fix Price's LFL sales increased by 1.9% in the 1st half of the year

8/8/24 FIXP

VK reported for 6 months of 2024 by IFRS

8/8/24 VKCO